Bone turnover markers in epileptic patients under chronic valproate therapy

Journal of Research in Medical Sciences

Volumn 18, Issue 4, 2013, Pages 338-340

  Zare, Mohammad ^a   Ghazvini, Mohammad R A ^b   Dashti, Maseumeh ^a   Najafi, Mohammad R ^a   Alavi Naeini, Amir M ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bone turnover markers; Epilepsy; Valproate sodium

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; PARATHYROID HORMONE; PHOSPHORUS; VALPROIC ACID;

ADULT; ARTICLE; BONE TURNOVER; CASE CONTROL STUDY; CONTROLLED STUDY; EPILEPSY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; SPECTROPHOTOMETRY;

EID: 84878777190     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lee RH, Lyles KW, Colón-Emeric C. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk. Am J Geriatr Pharmacother 2010;8:34-46.
2. Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006;35:177-81.
3. Tekgul H, Serdaroglu G, Huseyinov A, Gakben S. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol 2006;21:411-4.
4. Waheed A, Kettl PA. Low bone density with the use of valproate. Gen Hosp Psychiatry 2005;27:376-8.
5. Ecevit C, Aydoǧan A, Kavakli T, Altinaz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 2004;31:279-82.
6. Verrotti A, Agostinelli S, Coppola G, Parisi P, Chiarelli F. A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy. J Neurol Sci 2010;290:131-4.
7. Krishnamoorthy G, Karande S, Ahire N, Mathew L, Kulkarni M. Bone metabolism alteration on antiepileptic drug therapy. Indian J Pediatr 2009;76:377-83.
8. Kim SH, Lee JW, Choi KG, Chung HW, Lee HW. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy. Epilepsy Behav 2007;10:291-5.
9. Praticò AD, Pavone P, Scuderi MG, Li Volti G, Bernardini R, Cantarella G, et al. Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: A case report. Cases J 2009;2:7394.
10. Rauchenzauner M, Griesmacher A, Tatarczyk T, Haberlandt E, Strasak A, Zimmerhackl LB, et al. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children. Dev Med Child Neurol 2010;52:283-8.
11. Pack AM, Morrell MJ, Marcus R, Holloway L, Flaster E, Done S, et al. Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy. Ann Neurol 2005;57:252-7.
12. Pack AM, Morrell MJ, Randall A, McMahon DJ, Shane E. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology 2008;70:1586-93.
13. Chou IJ, Lin KL, Wang HS, Wang CJ. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan 2007;48:317-22.
14. Triantafyllou N, Lambrinoudaki I, Armeni E, Evangelopoulos EM, Boufidou F, Antoniou A, et al. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy. J Neurol Sci 2010;290:131-4.
15. Heo K, Rhee Y, Lee HW, Lee SA, Shin DJ, Kim WJ, et al. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy. Epilepsia 2011;52:1884-9.
16. Nicolaidou P, Georgouli H, Kotsalis H, Matsinos Y, Papadopoulou A, Fretzayas A, et al. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol 2006;21:205-9.